X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| TTM | $116.24M | +204.6% |
| 2024 | $38.16M | -64.5% |
| 2023 | $107.52M | +22.8% |
| 2022 | $87.57M | +19.2% |
| 2021 | $73.46M | +19.2% |
| 2020 | $61.64M | +33.6% |
| 2019 | $46.13M | +59.2% |
| 2018 | $28.98M | -19.4% |
| 2017 | $35.94M | +49.5% |
| 2016 | $24.05M | - |